NEW ZEALAND GAZETTE

No. 50

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name

(if any)

--- | --- | --- | ---

Ascorbic acid 125 mg, biotin 69 μg, cholecalciferol 200IU, cocarboxylase tetrahydrate 5.8 mg, cyanocobalamin 6 μg, dexpanthenol 16.15 mg, d1-alpha tocopherol 10.2 mg, folic acid 414 μg, nicotinamide 46 mg, pyridoxine hydrochloride 5.5 mg, retinol palmitate 3 500IU, riboflavin sodium phosphate 5.67 mg | Injection, powder | Clinitec Nutrition Clinique, Montargis, France; Aquitaine Pharm International, Pierre Fabre Medicament subsidiary, Idron, France; and Laboratoire Lipha, Semoy, France | Cernevit

Ferrous sulphate (anhydrous) 325 mg providing 105 mg elemental iron, sodium ascorbate 562.4 mg providing 500 mg ascorbic acid | Tablet, modified release | Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia; and Abbott Laboratories (UK) Limited, Queensborough, Kent, England | Ferrograd C

Fluorescein sodium 2.5 mg/mL, oxybuprocaine hydrochloride 4 mg/mL | Drops, eye solution | Akorn Manufacturing Inc., Decatur, Illinois, United States of America | Fluress

Factor VIII (recombinant) 250IU, 500IU, 1 000IU and water for injection 2.8 mL (as diluent) | Injection, powder with diluent | Bayer Corporation, Biological Products, Berkeley, California, United States of America | Helixate SF

Factor VIII (recombinant) 250IU, 500IU, 1 000IU and water for injection 2.8 mL (as diluent) | Injection, powder with diluent | Bayer Corporation, Biological Products, Berkeley, California, United States of America | Kogenate SF

Cetylpyridinium chloride 0.05% w/w, sodium fluoride 0.05% w/w | Mouthwash, solution | SmithKline Beecham Consumer Healthcare, Maidenhead, Berkshire, United Kingdom | Macleans Complete Care Coolmint Mouthwash

Cetylpyridinium chloride 0.05% w/w, sodium fluoride 0.05% w/w | Mouthwash, solution | SmithKline Beecham Consumer Healthcare, Maidenhead, Berkshire, United Kingdom | Macleans Complete Care Freshmint Mouthwash

Follitropin beta 50IU, 75IU, 100IU, 150IU, 200IU, 225IU, 250IU | Injection, solution | NV Organon, Oss, The Netherlands; and Organon (Ireland) Limited, Swords, County Dublin, Eire | Puregon

Hydroxyalkyl phosphonate (30% w/w solution) 1 mg/mL, poloxamine 10 mg/mL, polyhexamethylene biguanide 0.0078 mg/mL | Solution, contact lens | Bausch & Lomb Personal Products Division, Greenville, South Carolina, United States of America | ReNu MultiPlus Multi-Purpose

Dated this 23rd day of April 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

Internal Affairs

Marriage Act 1955

Marriage (Approval of Organisations) Notice

No. 5

Pursuant to the Marriage Act 1955, the Registrar-General of Marriages, hereby gives notice as follows:

Notice

1. This notice may be cited as the Marriage (Approval of Organisations) Notice No. 5.

2. The organisation specified in the Schedule hereto, is hereby declared to be an approved organisation for the purpose of the Marriage Act 1955.

Schedule
Storehouse Church.

Dated at Lower Hutt this 26th day of April 1999.

B. E. CLARKE, Registrar-General.

No. 6

Pursuant to the Marriage Act 1955, the Registrar-General of Marriages, hereby gives notice as follows:

Notice

1. This notice may be cited as the Marriage (Approval of Organisations) Notice No. 6.

2. The organisation specified in the Schedule hereto, is hereby declared to be an approved organisation for the purpose of the Marriage Act 1955.